Analysts Are Revising Their Forecasts Kiromic BioPharma (NASDAQ:KRBP)

Earnings results for Kiromic BioPharma (NASDAQ:KRBP)

Kiromic BioPharma, Inc. is estimated to report earnings on 08/13/2021. The upcoming earnings date is derived from an algorithm based on a company’s historical reporting dates. Our vendor, Zacks Investment Research, might revise this date in the future, once the company announces the actual earnings date.

Kiromic BioPharma last issued its earnings results on May 14th, 2021. The reported ($0.53) EPS for the quarter. Kiromic BioPharma has generated $0.00 earnings per share over the last year. Kiromic BioPharma has not formally confirmed its next earnings publication date, but the company’s estimated earnings date is Friday, August 13th, 2021 based off prior year’s report dates.

Analyst Opinion on Kiromic BioPharma (NASDAQ:KRBP)

Dividend Strength: Kiromic BioPharma (NASDAQ:KRBP)

Kiromic BioPharma does not currently pay a dividend. Kiromic BioPharma does not have a long track record of dividend growth.

Insiders buying/selling: Kiromic BioPharma (NASDAQ:KRBP)

In the past three months, Kiromic BioPharma insiders have not sold or bought any company stock. 34.51% of the stock of Kiromic BioPharma is held by insiders. A high percentage of insider ownership can be a sign of company health. Only 2.71% of the stock of Kiromic BioPharma is held by institutions.

Earnings and Valuation of Kiromic BioPharma (NASDAQ:KRBP

Kiromic BioPharma has a P/B Ratio of 2.17. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

More latest stories: here